news 2022

« BACK

Pharmacology



Results 41 - 60 of 62.


Health - Pharmacology - 16.03.2022
Mandatory vaccinations not the answer to boosting uptake among NHS staff
Mandatory vaccinations not the answer to boosting uptake among NHS staff
Just one in six (18%) healthcare workers thought mandatory vaccinations were the best solution to encourage more frontline staff to have a Covid-19 jab, finds new research led by UCL and the University of Leicester. As part of the UK-REACH longitudinal study, researchers carried out a survey of over 3,200 NHS healthcare workers, to understand how they felt about mandatory vaccinations, and find out what solutions they may have to address the problem of under-vaccination among colleagues.

Health - Pharmacology - 16.03.2022
Frailty may be reversible for some people with rheumatoid arthritis
Frailty may be reversible for some people with rheumatoid arthritis
Rheumatoid arthritis patients living with frailty may find their frailty is reversible following treatment, according to a new study. The research, published in RMD Open and led by the University of Glasgow, looked at frailty - a vulnerability to poor health-outcomes - in people with rheumatoid arthritis (RA).

Health - Pharmacology - 11.03.2022
Superhuman 20 second AI heart tool begins NHS roll-out
Superhuman 20 second AI heart tool begins NHS roll-out
A new artificial intelligence (AI) tool developed by UCL researchers can be used to detect heart disease in record speed, helping to improve care for heart patients. The first-of-its-kind AI tool, described in a new paper in the Journal of Cardiovascular Magnetic Resonance , analyses heart MRI scans in just 20 seconds whilst the patient is in the scanner.

Pharmacology - Health - 07.03.2022
Covid-19 vaccine rollout worsened existing health inequalities, find researchers
Covid-19 vaccine rollout worsened existing health inequalities, find researchers
The wide inequalities in Covid-19 vaccine uptake between people from ethnic minority groups and White British people are far greater than for the pre-pandemic flu jab, a study by University of Manchester health researchers has found. The findings, published in PLoS Medicine , overturns the prevailing view that ethnic inequalities in Covid-19 vaccine uptake simply follow previous trends in people's willingness to take up vaccination.

Pharmacology - Health - 03.03.2022
Global trials show drug eases symptoms of chronic cough
Global trials show drug eases symptoms of chronic cough
The world's first phase three trials of a new drug have shown that it can ease the often distressing symptom of chronic cough with few side effects. Principle researcher Jacky Smith, Professor of Respiratory Medicine at The University of Manchester and Honorary Consultant at Wythenshawe Hospital , Manchester University Foundation Trust and Director of NIHR Manchester Clinical Research Facility (CRF) , says Gefapixant has the potential to have a significant impact on the lives of thousands of sufferers.

Health - Pharmacology - 28.02.2022
Significant impacts of severe COVID-19 infection on pregnancy outcomes
Significant impacts of severe COVID-19 infection on pregnancy outcomes
A new analysis from Oxford Population Health has found that pregnant women that are 30 years old or more, overweight, of mixed ethnicity or have gestational diabetes have a greater risk of contracting severe COVID-19, which poses significant risks for both mother and baby. Throughout the COVID-19 pandemic, increasing evidence has shown that severe COVID-19 infection in pregnant women significantly raises the risk of adverse outcomes for both mother and baby.

Health - Pharmacology - 17.02.2022
Review highlights impact of Long COVID on cardiovascular system
Review highlights impact of Long COVID on cardiovascular system
The wide-ranging effects of Long COVID and the associated issues for healthcare providers have been revealed in a new review of the major studies into the condition, which specifically highlights the impact of Long COVID impact on the cardiovascular system. The review, published in the European Heart Journal , was conducted by researchers from the University of Oxford, the University of Wisconsin School of Medicine and Public Health, Royal Brompton Hospital and Imperial College, London, and the University of Zurich, Switzerland.

Health - Pharmacology - 15.02.2022
Cancer computer models identify new drug combinations to treat Covid-19
Cancer computer models identify new drug combinations to treat Covid-19
By adapting computer models originally developed to understand the biology of cancer cells, UCL scientists have identified new drug combinations with the potential to treat severe cases of Covid-19 infection at different stages of the disease. Researchers say the findings could help lower the number of Covid-19 related deaths and reduce the strain on healthcare systems.

Economics - Pharmacology - 14.02.2022
New book highlights how small biotech companies are outperforming big pharma
Biotech firms have developed nearly 40% more of key treatments for unmet medical needs, says a new book co-authored by Cambridge researchers. From Breakthrough to Blockbuster: The Business of Biotechnology , published today, shows how the small, inexperienced entrepreneurial companies making up the biotech industry have created more life-changing medicines than all of the large pharmaceutical companies combined.

Health - Pharmacology - 02.02.2022
Cancer drug could help fight HIV - new research
Stock-photo-female-medical-or-research-scientist-or-doctor-using-looking-at-a-test-tube-of-clear-solution-in-a-595303463.jpg A cancer drug called pembrolizumab might also help people with HIV, according to a new study. On the face of it, cancer and Aids have little to do with each other. One is caused by an excessive division of cells in the body, the other is caused by infection with a virus (HIV).

Health - Pharmacology - 31.01.2022
Individuals with immunodeficiency at high risk of mortality following SARS-CoV-2 infection
Patients with primary and secondary immunodeficiency are at higher risk of mortality following SARS-CoV-2 infection compared with the general population, according to a new study led by the University of Birmingham. The COVID-19 pandemic has disproportionately affected individuals with primary immunodeficiency (PID) and secondary immunodeficiency (SID).

Pharmacology - Health - 28.01.2022
Impaired antibody response to COVID-19 vaccination in blood cancer and arthritis patients being treated with widely used drug
Study shows impaired antibody response to COVID-19 vaccination in blood cancer and arthritis patients being treated with widely used drug Certain blood cancer and arthritis patients have a significantly reduced antibody response to double COVID-19 vaccination in the first six months of being treated with a widely used drug, reveals a new study.

Pharmacology - Health - 26.01.2022
Study profiles side-effects linked to common immunosuppressant
Study profiles side-effects linked to common immunosuppressant
New research led by University of Manchester and NIHR Manchester Biomedical Research Centre (BRC) scientists has profiled the side effects of methotrexate - a common drug used to treat arthritis and other autoimmune diseases. The authors hope their findings - published today in journal Rheumatology - will ease the concerns of patients before commencing treatment, who often lack knowledge of the drug, its impact and side effects.

Health - Pharmacology - 20.01.2022
More than a third of care home residents caught Covid-19 in early waves of pandemic
More than a third of care home residents caught Covid-19 in early waves of pandemic
More than a third of care home residents and a quarter of care home staff in England showed evidence of infection with SARS-CoV-2 during the first two waves of the pandemic, according to a new study led by UCL researchers. The study, published in The Lancet Healthy Longevity , looked at blood samples from nearly 5,000 residents (with a median age of 87) and staff (with a median age of 48) at 201 care homes across England between June 2020 and May 2021.

Pharmacology - Health - 19.01.2022
New blood cancer gene defect can be treated with existing drugs
A defective gene normally found in blood cancers could be treated with drugs already available for cancers with similar gene defects, scientists at the University of Birmingham and Queen's University Belfast have revealed. The researchers believe that PARP inhibitors could be used to treat patients with tumours carrying the defective SF3B1 gene.

Health - Pharmacology - 18.01.2022
'Off target' effects of drugs used for autoimmune disorders needs better treatment strategy
’Off target’ effects of drugs used for autoimmune disorders needs better treatment strategy
New therapies for autoimmune rheumatic diseases (AIRDs) that are designed to better regulate lipid (fat) metabolism, could significantly reduce the harmful side-effects caused by conventional treatments, finds a new large-scale review led by UCL researchers. AIRDs affect millions globally and include rheumatoid arthritis, lupus and Sjögren's syndrome - all with high rates of morbidity.

Pharmacology - Life Sciences - 13.01.2022
Promising novel treatment for Dry Eye Disease revealed by new research
Promising novel treatment for Dry Eye Disease revealed by new research
The University of Manchester, Seoul National University College of Medicine and Link Biologics Limited today announced that promising preclinical data on the treatment of Dry Eye Disease using a novel protein biological drug, Link_TSG6, have been published in the peer-reviewed journal, Ocular Surface .

Physics - Pharmacology - 13.01.2022
Keeping up with the first law of robotics: A new photonic effect for accelerated drug discovery
Keeping up with the first law of robotics: A new photonic effect for accelerated drug discovery
Physicists at the University of Bath and University of Michigan demonstrate a new photonic effect in semiconducting nanohelices. A new photonic effect in semiconducting helical particles with nanoscale dimensions has been discovered by an international team of scientists led by researchers at the University of Bath.

Health - Pharmacology - 05.01.2022
New test can identify if a patient has cancer and if it has spread
New test can identify if a patient has cancer and if it has spread
A publication by University of Oxford researchers describes a new minimally invasive and inexpensive blood test that can identify cancer in patients with non-specific symptoms. A University of Oxford study published in Clinical Cancer Research , a journal of the American Association for Cancer Research, outlines a new type of blood test that can be used to detect a range of cancers and whether these cancers have spread (metastasised) in the body.

Health - Pharmacology - 04.01.2022
Superbug MRSA arose in hedgehogs long before clinical use of antibiotics
Superbug MRSA arose in hedgehogs long before clinical use of antibiotics
Scientists have found evidence that a type of the antibiotic resistant superbug MRSA arose in nature long before the use of antibiotics in humans and livestock, which has traditionally been blamed for its emergence.